Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity-Reference-Cited by-同舟云学术

Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity

Published:2023 Issue:32 Volume:21 Page:6509-6523
ISSN:1477-0520
Container-title:Organic & Biomolecular Chemistry
language:en
Short-container-title:Org. Biomol. Chem.

Author:

Toubia Isabelle¹²,Nguyen Christophe³^ORCID,Diring Stéphane¹^ORCID,Onofre Mélanie³,Daurat Morgane⁴^ORCID,Gauthier Corentin³⁴^ORCID,Gary-Bobo Magali³^ORCID,Kobeissi Marwan²^ORCID,Odobel Fabrice¹^ORCID

Affiliation:

1. Nantes Université, CNRS, CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR 6230, 2, rue de la Houssinière - BP 92208, F-44000 NANTES, France

2. Laboratoire RammalRammal, Equipe de Synthèse Organique Appliquée SOA, Université Libanaise, Faculté des Sciences 5, Nabatieh, Lebanon

3. IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France

4. NanoMedSyn, 15 avenue Charles Flahault, 34293 Montpellier Cedex 5, France

Abstract

This study investigates the implementation of multivalent effect for PDT to enhance the selectivity of the treatment.

Funder

Campus France

Université Libanaise

Agence Nationale de la Recherche

Publisher

Royal Society of Chemistry (RSC)

Subject